Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
To Study the Effectiveness and Safety of Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes: a Multi-center, Prospective, Observational Study
1 other identifier
observational
528
1 country
1
Brief Summary
This study is a multi-center, prospective, observational clinical trial study. 528 full-term pregnant women will be enrolled as subjects, and the ratio of eligible subjects in the two groups is 1:1. In the cesarean section group, full term pregnant women with prelabor rupture of membrane (PROM) who are willing to try the trial of labor after cesarean (TOLAC) and in accordance with the criteria according to the 2016 China vaginal birth after cesarean (VBAC) clinical management guidelines will be enrolled and recorded by our homemade registration form of TOLAC. In the non-cesarean section group, pregnant women after 37 weeks of gestation with PROM but without vaginal labor contraindications will be enrolled. Whether in the cesarean section group or non-cesarean section group, if spontaneous labor does not occur, and they all will be induced by oxytocin. After 24 hours, their final delivery mode will be recorded. In the following 42 days postpartum, their complications and the neonatal outcome will be followed up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2022
CompletedStudy Start
First participant enrolled
March 30, 2022
CompletedFirst Posted
Study publicly available on registry
April 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedApril 19, 2022
April 1, 2022
2.8 years
February 8, 2022
April 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Vignial birth rate
After the treatment of oxytocin induction for up tp 24 hours, the mode of delivery will be konwn and recorded.
24 hours
Study Arms (2)
Cesarean section group
In the cesarean section group, all the pregnant women had only one prior cesarean section.
Non-cesarean section group
In the non-cesarean section group, all the pregnant women are primipara, and never had a cesarean section.
Interventions
In the two groups, if spontaneous labor does not occur after PROM, they all receive the oxytocin for up to 24h.
Eligibility Criteria
In the cesarean section group, the extra inclusion criteria includes: Only one prior low transverse uterine incision; Extra exclusion criteria: 1. With mutiple history of c esction; 2. Prior extensive transfundal uterine surgery, such as for fetal surgery, myomectomy, or uterine reconstruction; Prior classical vertical uterine incision, or an inverted "T" or "J" incision; 3. Short interpregnancy interval; 4. Prior uterine rupture or dehiscence, or cesarean scar pregnancy; 5. Evaluated fetal birth weight\> 4000 g. In the non-cesarean section group, the extra criteria should include: nulliparous
You may qualify if:
- Volunteers sign the informed consent;
- Age: 20-40 years;
- Singleton, a cephalic presentation;
- No contradiction to vaginal delivery;
- gestation: 37\~42 weeks;
- With prelabor rupture of membrane.
You may not qualify if:
- Konwn contraindication to vaginal delivery or severe complications;
- Multiple gestation;
- Uterine malformation;
- Severe psychiatric disorder;
- Without family's support.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Related Publications (4)
Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol. 2020 Mar;135(3):e80-e97. doi: 10.1097/AOG.0000000000003700.
PMID: 32080050BACKGROUNDBellussi F, Livi A, Diglio J, Lenzi J, Magnani L, Pilu G. Timing of induction for term prelabor rupture of membranes and intravenous antibiotics. Am J Obstet Gynecol MFM. 2021 Jan;3(1):100245. doi: 10.1016/j.ajogmf.2020.100245. Epub 2020 Oct 6.
PMID: 33451610BACKGROUNDFishel Bartal M, Sibai BM, Ilan H, Fried M, Rahav R, Alexandroni H, Schushan Eisan I, Hendler I. Trial of labor after cesarean (TOLAC) in women with premature rupture of membranes. J Matern Fetal Neonatal Med. 2020 Sep;33(17):2976-2982. doi: 10.1080/14767058.2019.1566312. Epub 2019 Jan 17.
PMID: 30652525BACKGROUNDMiddleton P, Shepherd E, Flenady V, McBain RD, Crowther CA. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3.
PMID: 28050900BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2022
First Posted
April 19, 2022
Study Start
March 30, 2022
Primary Completion
December 30, 2024
Study Completion
June 30, 2025
Last Updated
April 19, 2022
Record last verified: 2022-04